Uveal Malignant Melanoma: Management Options - Brachytherapy

Clinical Ophthalmic Oncology

Volumn , Issue , 2007, Pages 241-247

  Seregard, Stefan ^a   Damato, Bertil ^b   Fleming, Peter ^c  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45249114206     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3167-3.50046-2     Document Type: Chapter

References (37)

1. Moore RF Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol 1930, 14:145-152.
2. Stallard HB Radiotherapy of malignant intraocular neoplasm. Br J Ophthalmol 1948, 32:618-639.
3. Stallard HB Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 1966, 50:147-155.
4. Sealy R, le Roux PLM, Rapley F, et al. The treatment of ophthalmic tumors with low-energy sources. Br J Radiol 1976, 49:551-554.
5. Packer S, Rotman M Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology 1974, 87:582-590.
6. Lommatzsch PK Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators. Surv Ophthalmol 1974, 19:85-100.
7. Straatsma BR, Fine SL, Earle JD, et al. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 1988, 95:1000-1004.
8. Bergman L, Nilsson B, Lundell G, et al. Ruthenium brachytherapy for uveal melanoma, 1979-2003. Survival and functional outcomes in the Swedish population. Ophthalmology 2005, 112:834-840.
9. Damato BE, Patel I, Campbell IR, et al. Local tumor control after (106)Ru brachytherapy of choroidal melanoma. Int J Radiat Oncol Biol Phys 2005, 63:385-391.
10. Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. 1. Visual acuity after 3 years. COMS Report no. 16. Ophthalmology 2001, 108:348-366. The Collaborative Ocular Melanoma Study Group.
11. The COMS Randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS Report no. 18. Arch Ophthalmol 2001, 119:969-982. The Collaborative Ocular Melanoma Study Group.
12. Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no.19. Ophthalmology 2002, 109:2197-2206.
13. Finger PT, Berson A, Ng T, Szechter A Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study. Int J Radiat Oncol Biol Phys 2002, 54:1438-1445.
14. Karvat A, Duzenli C, Ma R, et al. The treatment of choroidal melanoma with 198 Au plaque brachytherapy. Radiother Oncol 2001, 59:153-156.
15. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma: visual outcome in 1106 consecutive patients. Arch Ophthalmol 2000, 18:1219-1228.
16. Missotten L, Dirven W, Van der Schueren A, et al. Results of treatment of choroidal malignant melanoma with high-dose-rate strontium-90 brachytherapy. A retrospective study of 46 patients treated between 1983 and 1995. Graefes Arch Clin Exp Ophthalmol 1998, 236:164-173.
17. Soares CG, Vynckier S, Jarvinen H, et al. Dosimetry of beta-ray ophthalmic applicators: comparison of different measurement methods. Med Phys 2001, 28:1373-1384.
18. Gunduz K, Shilds CL, Shields JA, et al. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Am J Ophthalmol 2000, 130:97-102.
19. Williams DF, Mieler WF, Jaff GJ, et al. Magnetic resonance imaging of juxtapapillary plaques in cadaver eyes. Br J Ophthalmol 1990, 74:43-46.
20. Tabandeh H, Chaudhry NA, Murray TG, et al. Intraoperative echographic localization of iodine-125 episcleral plaque for brachytherapy of choroidal melanoma. Am J Ophthalmol 2000, 129:199-204.
21. Damato B, Patel I, Campbell IR, et al. Visual acuity after ruthenium (106) brachytherapy of choridal melanomas. Int J Radiat Oncol Biolol Phys 2005, 63:392-400.
22. Laube T, Fluhs D, Kessler C, et al. Determination of surgeon's absorbed dose in iodine 125 and ruthenium 106 ophthalmic plaque surgery. Ophthalmology 2000, 107:366-368.
23. Shields CL, Naseripour M, Shields JA, et al. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications. Am J Ophthalmol 2003, 135:648-656.
24. Fluhs D, Anastassiou G, Wening J, et al. The design and the dosimetry of binuclide radioactive ophthalmic applicators. Med Phys 2004, 31:1481-1488.
25. Astrahan MA, Szechter A, Finger PT Design and dosimetric considerations of a modified COMS plaque: the reusable 'seed-guide' insert. Med Phys 2005, 32:2706-2716.
26. Seregard S, Landau I Transpupillary thermotherapy as an adjunct to ruthenium plaque radiotherapy for choroidal melanoma. Acta Ophthalmol Scand 2001, 79:19-22.
27. Bartlema YM, Oosterhuis JA, Journée-De Korver JG, et al. Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience. Br J Ophthalmol 2003, 87:1370-1373.
28. Damato BE, Foulds WS Surgical resection of choroidal melanoma. The retina 2006, 769-778. Mosby, St Louis. A.P. Schachat, S.J. Ryan (Eds.).
29. Puusaari I, Heikkonen J, Kivela T Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimated plaques. Invest Ophthalmol Vis Sci 2004, 45:3425-3434.
30. Puusaari I, Heikkonen J, Kivela T Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology 2004, 111:1768-1777.
31. Robertson DM, Fuller DG, Anderson RE A technique for accurate placement of epscleral iodine-125 plaques. Am J Ophthalmol 1987, 103:63-65.
32. Finger PT Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 2000, 84:1068-1070.
33. Summanen P, Immonen I, Kivela T, et al. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol 1996, 80:732-739.
34. Finger PT, Kurli M Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 2005, 89:730-738.
35. Shields CL, Shields JA, Karlsson U, et al. Reasons for enucleation after plaque radiotherapy for uveal melanoma. Clinical findings. Ophthalmology 1989, 96:919-923.
36. Puusaari I, Heikkonen J, Summanen P, et al. Iodine brachtherapy as an alternative to enucleation for large uveal melanoma. Ophthalmology 2003, 110:2223-2234.
37. Seregard S, Lundell G, Lax I, et al. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma. Acta Ophthalmol Scand 1997, 75:148-154.